Google Alert - cannabidiol for epilepsy

	cannabidiol for epilepsy Daily update ⋅ August 19, 2019
	NEWS
	CBD capsules reduce seizures by 82% in trial The Leaf Desk The results have been published in Epilepsy & Behaviour, a bimonthly ... says the results compare favourably to other similar studies of cannabidiol. Flag as irrelevant
	Childhood Absence Epilepsy Treatment Market SWOT Analysis including key players Pfizer ... BombardNews Analysts also analyzed the ongoing trends in Childhood Absence Epilepsy ... Types: Ethosuximide, Valproate, Lamotrigine, CX-8998, Cannabidiol Oral Solution. Major Applications are as follows: Typical Absence Seizures, Atypical ... Flag as irrelevant
	Roosevelt Investment Group Raised Its Gw Pharmaceuticals (GWPH) Holding by $7.18 Million ... CryptoCoinsTribune ... 16/05/2018 – Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy; 13/03/2018 – GW Pharmaceuticals Announces ... Flag as irrelevant
	Gw Pharmaceuticals Plc (Put) (GWPH) Holder Sio Capital Management Cut Holding by $5.61 ... The EN Herald ... PANEL MEETING; 19/04/2018 – Epilepsy Foundation Testifies Before FDA Advisory Committee in Support of Potential First-Ever Cannabidiol Drug ... Flag as irrelevant
	United Technologies (UTX) Holder Lakewood Capital Management LP Lowered Its Stake by $4.16 ... The EN Herald Some Historical GWPH News: 17/04/2018 – GW cannabis-derived epilepsy drug gets positive FDA staff review; ... Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the; 17/04/2018 – ADRs End ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback